Sexual Mixing by HIV Status and Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men: Addressing Information Bias.


Journal

Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644

Informations de publication

Date de publication:
01 11 2022
Historique:
pubmed: 28 7 2022
medline: 14 10 2022
entrez: 27 7 2022
Statut: ppublish

Résumé

Population-level estimates of sexual network mixing for parameterizing prediction models of pre-exposure prophylaxis (PrEP) effectiveness are needed to inform prevention of HIV transmission among men who have sex with men (MSM). Estimates obtained by egocentric sampling are vulnerable to information bias due to incomplete respondent knowledge. We estimated patterns of serosorting and PrEP sorting among MSM in the United States using data from a 2017-2019 egocentric sexual network study. Respondents served as proxies to report the HIV status and PrEP use of recent sexual partners. We contrasted results from a complete-case analysis (unknown HIV and PrEP excluded) versus a bias analysis with respondent-reported data stochastically reclassified to simulate unobserved self-reported data from sexual partners. We found strong evidence of preferential partnering across analytical approaches. The bias analysis showed concordance between sexual partners of HIV diagnosis and PrEP use statuses for MSM with diagnosed HIV (39%; 95% simulation interval: 31, 46), MSM who used PrEP (32%; 21, 37), and MSM who did not use PrEP (83%; 79, 87). The fraction of partners with diagnosed HIV was higher among MSM who used PrEP (11%; 9, 14) compared with MSM who did not use PrEP (4%; 3, 5). Comparatively, across all strata of respondents, the complete-case analysis overestimated the fractions of partners with diagnosed HIV or PrEP use. We found evidence consistent with HIV and PrEP sorting among MSM, which may decrease the population-level effectiveness of PrEP. Bias analyses can improve mixing estimates for parameterization of transmission models.

Sections du résumé

BACKGROUND
Population-level estimates of sexual network mixing for parameterizing prediction models of pre-exposure prophylaxis (PrEP) effectiveness are needed to inform prevention of HIV transmission among men who have sex with men (MSM). Estimates obtained by egocentric sampling are vulnerable to information bias due to incomplete respondent knowledge.
METHODS
We estimated patterns of serosorting and PrEP sorting among MSM in the United States using data from a 2017-2019 egocentric sexual network study. Respondents served as proxies to report the HIV status and PrEP use of recent sexual partners. We contrasted results from a complete-case analysis (unknown HIV and PrEP excluded) versus a bias analysis with respondent-reported data stochastically reclassified to simulate unobserved self-reported data from sexual partners.
RESULTS
We found strong evidence of preferential partnering across analytical approaches. The bias analysis showed concordance between sexual partners of HIV diagnosis and PrEP use statuses for MSM with diagnosed HIV (39%; 95% simulation interval: 31, 46), MSM who used PrEP (32%; 21, 37), and MSM who did not use PrEP (83%; 79, 87). The fraction of partners with diagnosed HIV was higher among MSM who used PrEP (11%; 9, 14) compared with MSM who did not use PrEP (4%; 3, 5). Comparatively, across all strata of respondents, the complete-case analysis overestimated the fractions of partners with diagnosed HIV or PrEP use.
CONCLUSIONS
We found evidence consistent with HIV and PrEP sorting among MSM, which may decrease the population-level effectiveness of PrEP. Bias analyses can improve mixing estimates for parameterization of transmission models.

Identifiants

pubmed: 35895578
doi: 10.1097/EDE.0000000000001525
pii: 00001648-202211000-00006
pmc: PMC9561018
mid: NIHMS1822982
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

808-816

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI138783
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH112449
Pays : United States

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Centers for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2010–2016: HIV Surveillance Supplemental Report . 2019. Available at: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html . Accessed March 1, 2021.
Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321:844–845.
Grant RM, Lama JR, Anderson PL, et al.; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–2599.
McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387:53–60.
Anderson PL, Glidden DV, Liu A, et al.; iPrEx Study Team. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4:151ra125.
Jenness SM, Goodreau SM, Rosenberg E, et al. Impact of the Centers for Disease Control’s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. J Infect Dis. 2016;214:1800–1807.
Sullivan PS, Carballo-Diéguez A, Coates T, et al. Successes and challenges of HIV prevention in men who have sex with men. Lancet. 2012;380:388–399.
Jenness SM, Maloney KM, Smith DK, et al. Addressing gaps in HIV preexposure prophylaxis care to reduce racial disparities in HIV incidence in the United States. Am J Epidemiol. 2019;188:743–752.
Centers for Disease Control and Prevention. US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update: A Clinical Practice Guideline . 2018. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf . Accessed 12 March 2021.
Wang L, Moqueet N, Simkin A, et al. Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis. AIDS. 2021;35:1113–1125.
Weiss KM, Goodreau SM, Morris M, et al. Egocentric sexual networks of men who have sex with men in the United States: results from the ARTnet study. Epidemics. 2020;30:100386.
Purcell DW, Higa D, Mizuno Y, Lyles C. Quantifying the harms and benefits from serosorting among HIV-negative gay and bisexual men: a systematic review and meta-analysis. AIDS Behav. 2017;21:2835–2843.
Kennedy CE, Bernard LJ, Muessig KE, et al. Serosorting and HIV/STI infection among HIV-negative MSM and transgender people: a systematic review and meta-analysis to inform WHO guidelines. J Sex Transm Dis. 2013;2013:583627.
Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321:451–452.
Rendina HJ, Parsons JT. Factors associated with perceived accuracy of the Undetectable = Untransmittable slogan among men who have sex with men: implications for messaging scale-up and implementation. J Int AIDS Soc. 2018;21:e25055.
Card KG, Armstrong HL, Lachowsky NJ, et al. Belief in treatment as prevention and its relationship to HIV status and behavioral risk. J Acquir Immune Defic Syndr. 2018;77:8–16.
Newcomb ME, Mongrella MC, Weis B, McMillen SJ, Mustanski B. Partner disclosure of PrEP use and undetectable viral load on geosocial networking apps: frequency of disclosure and decisions about condomless sex. J Acquir Immune Defic Syndr. 2016;71:200–206.
Wang L, Moqueet N, Lambert G, et al. Population-level sexual mixing according to HIV status and preexposure prophylaxis use among men who have sex with men in Montreal, Canada: implications for HIV prevention. Am J Epidemiol. 2020;189:44–54.
Grov C, Jonathan Rendina H, Patel VV, Kelvin E, Anastos K, Parsons JT. Prevalence of and factors associated with the use of HIV serosorting and other biomedical prevention strategies among men who have sex with men in a US nationwide survey. AIDS Behav. 2018;22:2743–2755.
Prescott MR, Hern J, Petersen M, Santos GM. Does HIV pre-exposure prophylaxis modify the effect of partnership characteristics on condom use? A cross-sectional study of sexual partnerships among men who have sex with men in San Francisco, California. AIDS Patient Care STDS. 2019;33:167–174.
Chow EPF, Phillips TR, Bradshaw CS, Chen MY, Fairley CK. Brief report: sexual mixing patterns by HIV status and PrEP use among men who have sex with men partnerships in Melbourne, 2011-2018. J Acquir Immune Defic Syndr. 2020;83:99–102.
Martinez JE, Jonas KJ. Pre-exposure prophylaxis sorting among men who have sex with men. AIDS Care. 2019;31:388–396.
Centers for Disease Control and Prevention. HIV testing among men who have sex with men--21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2011;60:694–699.
Grey JA, Rothenberg R, Sullivan PS, Rosenberg ES. Racial differences in the accuracy of perceived partner HIV status among men who have sex with men (MSM) in Atlanta, Georgia. J Int Assoc Provid AIDS Care. 2015;14:26–32.
Imahashi M, Fujimoto K, Kuhns LM, Amith M, Schneider JA. Network overlap and knowledge of a partner’s HIV status among young men who have sex with men. AIDS Care. 2019;31:1533–1539.
Marcus U, Schink SB, Sherriff N, et al.; Sialon II Network. HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study. BMC Infect Dis. 2017;17:730.
Marcus U, an der Heiden M, Gassowski M, Kruspe M, Drewes J. The impact of meeting locations for men having sex with men on the risk for bacterial sexually transmitted infections: analyses from a cross-sectional online survey. BMJ Open. 2015;5:e009107.
Brown MJ, Serovich JM, Kimberly JA, Umasabor-Bubu O. Disclosure and self-efficacy among HIV-positive men who have sex with men: a comparison between older and younger adults. AIDS Patient Care STDS. 2015;29:625–633.
Goedel WC, Schneider JA, Hagen D, Duncan DT. Serodiscussion, perceived seroconcordance, and sexual risk behaviors among dyads of men who have sex with men who use geosocial-networking smartphone applications in London. J Int Assoc Provid AIDS Care. 2017;16:233–238.
Przybyla S, Golin C, Widman L, Grodensky C, Earp JA, Suchindran C. Examining the role of serostatus disclosure on unprotected sex among people living with HIV. AIDS Patient Care STDS. 2014;28:677–684.
Medina MM, Crowley C, Montgomery MC, et al. Disclosure of HIV serostatus and pre-exposure prophylaxis use on internet hookup sites among men who have sex with men. AIDS Behav. 2019;23:1681–1688.
Abler L, Sikkema KJ, Watt MH, Hansen NB, Wilson PA, Kochman A. Depression and HIV serostatus disclosure to sexual partners among newly HIV-diagnosed men who have sex with men. AIDS Patient Care STDS. 2015;29:550–558.
Sanchez TH, Sineath RC, Kahle EM, Tregear SJ, Sullivan PS. The annual American men’s internet survey of behaviors of men who have sex with men in the United States: protocol and key indicators report 2013. JMIR Public Health Surveill. 2015;1:e3.
Shardell M, Simonsick EM, Hicks GE, Resnick B, Ferrucci L, Magaziner J. Sensitivity analysis for nonignorable missingness and outcome misclassification from proxy reports. Epidemiology. 2013;24:215–223.
Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Series B Stat Methodol. 2009;71:319–392.
Harris NS, Johnson AS, Huang YA, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis - United States, 2013-2018. MMWR Morb Mortal Wkly Rep. 2019;68:1117–1123.
Sullivan PS, Sanchez TH, Zlotorzynska M, et al. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017. J Int AIDS Soc. 2020;23:e25461.
Wang L, Tan DHS, Mishra S. Evidence of nonrandom mixing by pre-exposure prophylaxis use among men who have sex with men partnerships in Melbourne, 2016 to 2018. J Acquir Immune Defic Syndr. 2020;84:e22–e23.
Huang YA, Tao G, Smith DK, Hoover KW. Persistence with human immunodeficiency virus pre-exposure prophylaxis in the United States, 2012-2017. Clin Infect Dis. 2021;72:379–385.
Marcus JL, Hurley LB, Hare CB, et al. Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73:540–546.
Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2018. HIV Surveillance Supplemental Report. 2020;25:104.
Kanny D, Jeffries WL 4th, Chapin-Bardales J, et al.; National HIV Behavioral Surveillance Study Group. Racial/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men - 23 urban areas, 2017. MMWR Morb Mortal Wkly Rep. 2019;68:801–806.
Rubin DB. Inference and missing data. Biometrika. 1976;63:581–592.
Lash TL, Fink AK, Fox MP. Applying Quantitative Bias Analysis to Epidemiologic Data. Springer; 2009.

Auteurs

Kevin M Maloney (KM)

From the Department of Epidemiology, Emory University, Atlanta, GA.
Department of Population Health Sciences, Georgia State University, Atlanta, GA.

David Benkeser (D)

Department of Biostatistics, Emory University, Atlanta, GA.

Patrick S Sullivan (PS)

From the Department of Epidemiology, Emory University, Atlanta, GA.

Colleen Kelley (C)

Department of Medicine, Emory University, Atlanta, GA.

Travis Sanchez (T)

From the Department of Epidemiology, Emory University, Atlanta, GA.

Samuel M Jenness (SM)

From the Department of Epidemiology, Emory University, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH